You can buy or sell Evofem and other stocks, options, ETFs, and crypto commission-free!
Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. Read More The company was founded in 2007 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Seeking AlphaMar 1
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2018 Results - Earnings Call Transcript
Evofem Biosciences, Inc. (NASDAQ:EVFM) Q4 2018 Results Earnings Conference Call March 1, 2019 11:00 AM ET Company Participants Amy Raskopf - IR Saundra Pelletier - CEO Jay File - CFO Russ Barrans - CCO Kelly Culwell - CMO Conference Call Participants Randall Stanicky - RBC Capital Markets Leland Gershell - Oppenheimer Yasmeen Rahimi - Roth Capital Partners Ram Selvaraju - H.C. Wainwright Carl Burns - Lawson Northern Securities Matthew Lillis - Cantor Fitzgerald Operator Good day, ladies and g...
Expected May 10, Pre-Market